SKA3 and ovarian cancer: The findings for breast, colorectal, and ovarian cancers were inconsistent with those on PrognoScan, as high SKA3 expression levels had no discernible effect on the prognosis of three cancers, including BRCA (OS: HR = 1.2, log-rank P = 0.23) (Fig. 3F), COAD (DFS: HR = 1.1, log-rank P = 0.61) (Fig. 3G), and OVC (OS: HR = 0.95, log-rank P = 0.67) (Fig. 3H).